Current and historical daily PE Ratio for PT Kalbe Farma Tbk (
) from 2004 to Jun 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. PT Kalbe Farma Tbk stock (FRA:LCLA) PE ratio as of Jun 21 2024 is 25.3.
More Details
PT Kalbe Farma Tbk (FRA:LCLA) PE Ratio (TTM) Chart
PT Kalbe Farma Tbk (FRA:LCLA) PE Ratio (TTM) Historical Data
View and export this data going back to 2004. Start your Free Trial
Total 1265
- 1
- 2
- 3
- 4
- 5
- 6
- 15
PT Kalbe Farma Tbk PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-22 | 20.3 | 2024-04-18 | 18.8 |
2024-06-20 | 20.3 | 2024-04-17 | 19.1 |
2024-06-19 | 20.4 | 2024-04-16 | 19.5 |
2024-06-18 | 20.3 | 2024-04-15 | 19.8 |
2024-06-17 | 20.3 | 2024-04-12 | 19.6 |
2024-06-14 | 20.5 | 2024-04-11 | 19.6 |
2024-06-13 | 20.5 | 2024-04-10 | 18.4 |
2024-06-12 | 20.3 | 2024-04-09 | 19.5 |
2024-06-11 | 20.5 | 2024-04-08 | 19.6 |
2024-06-10 | 20.6 | 2024-04-05 | 19.8 |
2024-06-07 | 20.5 | 2024-04-04 | 19.8 |
2024-06-06 | 20.3 | 2024-04-03 | 20.0 |
2024-06-05 | 20.0 | 2024-04-02 | 19.5 |
2024-06-04 | 20.1 | 2024-03-28 | 19.6 |
2024-06-03 | 19.8 | 2024-03-27 | 19.4 |
2024-05-31 | 18.0 | 2024-03-26 | 20.0 |
2024-05-30 | 20.0 | 2024-03-25 | 20.3 |
2024-05-29 | 19.8 | 2024-03-22 | 19.9 |
2024-05-28 | 20.4 | 2024-03-21 | 19.5 |
2024-05-27 | 20.5 | 2024-03-20 | 19.8 |
2024-05-24 | 20.5 | 2024-03-19 | 18.9 |
2024-05-23 | 20.5 | 2024-03-18 | 18.9 |
2024-05-22 | 20.5 | 2024-03-15 | 19.3 |
2024-05-21 | 19.8 | 2024-03-14 | 19.3 |
2024-05-20 | 20.0 | 2024-03-13 | 19.1 |
2024-05-17 | 19.8 | 2024-03-12 | 19.4 |
2024-05-16 | 19.0 | 2024-03-11 | 19.4 |
2024-05-15 | 18.8 | 2024-03-08 | 19.3 |
2024-05-14 | 18.5 | 2024-03-07 | 19.6 |
2024-05-13 | 18.6 | 2024-03-06 | 20.0 |
2024-05-10 | 18.8 | 2024-03-05 | 19.8 |
2024-05-09 | 18.8 | 2024-03-04 | 20.0 |
2024-05-08 | 18.8 | 2024-03-01 | 20.0 |
2024-05-07 | 19.1 | 2024-02-29 | 20.0 |
2024-05-06 | 19.1 | 2024-02-28 | 19.5 |
2024-05-03 | 19.4 | 2024-02-27 | 19.6 |
2024-05-02 | 19.6 | 2024-02-26 | 19.8 |
2024-04-30 | 19.1 | 2024-02-23 | 19.9 |
2024-04-29 | 18.4 | 2024-02-22 | 20.0 |
2024-04-26 | 18.6 | 2024-02-21 | 20.1 |
2024-04-25 | 19.0 | 2024-02-20 | 20.3 |
2024-04-24 | 18.5 | 2024-02-19 | 20.0 |
2024-04-23 | 18.8 | 2024-02-16 | 20.1 |
2024-04-22 | 18.6 | 2024-02-15 | 20.0 |
2024-04-19 | 18.5 | 2024-02-14 | 20.3 |
PT Kalbe Farma Tbk (FRA:LCLA) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
![PT Kalbe Farma Tbk PT Kalbe Farma Tbk logo](https://static.gurufocus.com/logos/0C00003AL7.png?14)
PT Kalbe Farma Tbk
NAICS : 325412
ISIN : ID1000125107
Share Class Description:
FRA:LCLA: Ordinary SharesDescription
PT Kalbe Farma Tbk is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.